Sood is "partially right," because USRX did in fact, fall below his revenue estimates. He was looking for $662 Million, and USRX came in at about $645 Million.
Yes, he was wrong about the EPS, but like I said, there were "quality" issues.
Again, Janice, Sood thinks USRX is great in the long term. He's looking for the March quarter to be weak, so he is advising his clients to hold-off on buying the stock in the short term.
And I also need to reiterate that other firms lowered their numbers on USRX today.
In MY opinion, the March quarter's consensus estimate are close, with a small +/-. Further, I think that Calendar97 numbers are too low, because I'm personally looking for USRX to have an extremely strong second half.
I agree with Sood in that there is no rush to buy the stock today. IMO, it is basically gonna be a market performer. With that, the market could correct in the next couple of months, at which time USRX would be a steal. Note, that USRX is NOT strong enough to resist if the market comes in....
Sal Habash |
